U.S. Patent and Trademark Office Receives ATEA Pharmaceuticals's Patent Application for Highly Active Compounds Against COVID-19

Published date11 September 2021
Publication titleGlobal IP News (India)
The patent application number is 17/094541. International Patent Classification codes are A61K 31/7076 20060101 A61K031/7076, A61K 9/00 20060101 A61K009/00, A61K 9/08 20060101 A61K009/08 and A61P 31/14 20060101 A61P031/14. Cooperative Patent Classification codes are A61P 31/14 20180101, A61K 9/08 20130101, A61K 9/0019 20130101, A61K 31/7076 20130101 and A61K 9/0053 20130101.

U.S. Patent and Trademark Office has released the abstract. According to the abstract, "The present invention is the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT